ArticleJournal of hospital medicine2022

Safety and effectiveness of apixaban versus warfarin for acute venous thromboembolism in patients with end-stage kidney disease: A national cohort study.

Michael I Ellenbogen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.